NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · page 18 of 30
Study uses male DIO-NASH mice with 30-week GAND feeding and 9-week treatment regimen.
Regulatory filing · comparison_table · analyze_data · overcrowded density
Slide locked Sign in to view
Slide schematic 8/8
chart 2/2 diagram 1/1 image 1/1 list 1/1 source-note 1/1 title 2/2
Components 8
bar-vertical bar-vertical timeline illustration bullet source-note action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.